Multiplexed cytokine and antigen mRNA administration generates durable anti-tumor immunity against pancreatic cancer

Chaitanya N. Parikh, Kelly D. DeMarco, Nikita Bhalerao, Hadiya K. Giwa, Griffin I. Kane, Ronnie W. Dinnell, Boyang Ma, Haruka Mori, Meghan L. Brassil, Katherine C. Murphy, Zhen Zhao, Calvin Johnson, Shriram Ramani, Lin Zhou, Loretah Chibaya, Youwei Qiao, Kai Hu, Lihua Julie Zhu, Brian C. Lewis, Wen Xue, Jason R. Pitarresi, Prabhani U. Atukorale, Marcus Ruscetti · 2026

Read Multiplexed cytokine and antigen mRNA administration generates durable anti-tumor immunity against pancreatic cancer by Chaitanya N. Parikh, Kelly D. DeMarco, Nikita Bhalerao, Hadiya K. Giwa, Griffin I. Kane, Ronnie W. Dinnell, Boyang Ma, Haruka Mori, Meghan L. Brassil, Katherine C. Murphy, Zhen Zhao, Calvin Johnson, Shriram Ramani, Lin Zhou, Loretah Chibaya, Youwei Qiao, Kai Hu, Lihua Julie Zhu, Brian C. Lewis, Wen Xue, Jason R. Pitarresi, Prabhani U. Atukorale, Marcus Ruscetti (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13427719.txt.

Description

Chaitanya N. Parikh and a large team report, in 2026, an mRNA cocktail that wakes the immune system inside pancreatic tumors. Pancreatic cancer usually shuts immune cells out and lacks the signal chemicals that call them in. The team packed messenger RNA for five such signals, including two interleukins and an interferon, into single injections. Injected into mouse tumors, the mix briefly produced the signals in place.

Tumors shrank, scarring eased, and natural killer cells plus killer T cells switched on. Adding mRNA for tumor antigens, the markers that teach T cells what to attack, extended survival after one dose. When the full cocktail rode in nanoparticles through the bloodstream, half the mice with natural pancreatic tumors were cured. Human testing is distant, but the strategy targets a cancer that resists most immune therapy.

Catalog record

CREATORChaitanya N. Parikh, Kelly D. DeMarco, Nikita Bhalerao, Hadiya K. Giwa, Griffin I. Kane, Ronnie W. Dinnell, Boyang Ma, Haruka Mori, Meghan L. Brassil, Katherine C. Murphy, Zhen Zhao, Calvin Johnson, Shriram Ramani, Lin Zhou, Loretah Chibaya, Youwei Qiao, Kai Hu, Lihua Julie Zhu, Brian C. Lewis, Wen Xue, Jason R. Pitarresi, Prabhani U. Atukorale, Marcus Ruscetti
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE126608
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13427719

Browse the full library · About the Tower of Babel